92 related articles for article (PubMed ID: 7117636)
21. [Comparative immunologic studies in PUVA and SUP (selected ultraviolet phototherapy) treatments].
Simon N; Hunyadi J
Z Hautkr; 1982 Sep; 57(17):1268-73. PubMed ID: 7148058
[TBL] [Abstract][Full Text] [Related]
22. Dark effect of 8-methoxypsoralen (8-MOP) on lymphocytes.
Lischka G; Decker E
Arch Dermatol Res; 1978 May; 261(3):267-72. PubMed ID: 686810
[TBL] [Abstract][Full Text] [Related]
23. An intraindividual comparative study of psoralen-UVA erythema induced by bath 8-methoxypsoralen and 4, 5', 8-trimethylpsoralen.
Man I; McKinlay J; Dawe RS; Ferguson J; Ibbotson SH
J Am Acad Dermatol; 2003 Jul; 49(1):59-64. PubMed ID: 12833009
[TBL] [Abstract][Full Text] [Related]
24. Apoptosis induced by membrane damage in human lymphocytes; effects of arachidonic acid and its photoproducts.
Zarebska Z; Zielińska J; Zhukov I; Maśliński W
Acta Biochim Pol; 2005; 52(1):179-94. PubMed ID: 15827616
[TBL] [Abstract][Full Text] [Related]
25. [Treatment of plaque-type psoriasis with cream-PUVA therapy].
Steinmeyer K; Grundmann-Kollmann M; Podda M; Kaufmann R
Hautarzt; 2001 Oct; 52(10):885-7. PubMed ID: 17690819
[TBL] [Abstract][Full Text] [Related]
26. Photochemotherapy and the eye: photoprotective factors.
Glew WB; McKeever G; Roberts WP; Malinin G; Nigra TP
Trans Am Ophthalmol Soc; 1980; 78():243-54. PubMed ID: 7257058
[TBL] [Abstract][Full Text] [Related]
27. Reduction of treatment frequency and UVA dose does not substantially compromise the antipsoriatic effect of oral psoralen-UVA.
Legat FJ; Hofer A; Quehenberger F; Kahofer P; Kerl H; Wolf P
J Am Acad Dermatol; 2004 Nov; 51(5):746-54. PubMed ID: 15523353
[TBL] [Abstract][Full Text] [Related]
28. The effect of psoralen plus ultraviolet A in vitro in HUT-78 enhances by 5-aminolevulinic acid.
Akita Y; Watanabe D; Yanagishita T; Kuhara T; Kawamura C; Masuda Y; Kawada M; Nakaseko H; Tamada Y; Matsumoto Y
Photodermatol Photoimmunol Photomed; 2007; 23(2-3):95-7. PubMed ID: 17523931
[TBL] [Abstract][Full Text] [Related]
29. The PUVA-turban as a new option of applying a dilute psoralen solution selectively to the scalp of patients with alopecia areata.
Behrens-Williams SC; Leiter U; Schiener R; Weidmann M; Peter RU; Kerscher M
J Am Acad Dermatol; 2001 Feb; 44(2):248-52. PubMed ID: 11174382
[TBL] [Abstract][Full Text] [Related]
30. Differential sensitivity of T lymphocytes and hematopoietic precursor cells to photochemotherapy with 8-methoxypsoralen and ultraviolet A light.
Mabed M; Coffe C; Racadot E; Angonin R; Pavey JJ; Tiberghien P; Herve P
Ann Hematol; 2006 Jan; 85(1):17-24. PubMed ID: 16208471
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic and prophylactic effects of PUVA photochemotherapy on atopic dermatitis-like lesions in NC/Nga mice.
Miyauchi-Hashimoto H; Okamoto H; Sugihara A; Horio T
Photodermatol Photoimmunol Photomed; 2005 Jun; 21(3):125-30. PubMed ID: 15888128
[TBL] [Abstract][Full Text] [Related]
32. PUVA apoptotic response in activated and resting human lymphocytes.
Heng AE; Sauvezie B; Genestier L; Demeocq F; Dosgilbert A; Deteix P
Transfus Apher Sci; 2003 Feb; 28(1):43-50. PubMed ID: 12620268
[TBL] [Abstract][Full Text] [Related]
33. PUVA therapy damages psoriatic and normal lymphoid cells within milliseconds.
Böhm F; Meffert H; Bauer E
Arch Dermatol Res; 1986; 279(1):16-9. PubMed ID: 3813650
[TBL] [Abstract][Full Text] [Related]
34. [Determination of the 8-methoxypsoralen spectrum of action in vitro on lymphocytes].
Gast W; Rytter M; Biella U; Walther T; Haustein UF
Dermatol Monatsschr; 1988; 174(7):419-20. PubMed ID: 3169328
[No Abstract] [Full Text] [Related]
35. [Destruction of peripheral lymphocytes by 8-MOP and UVA].
Meffert H; Böhm F; Sönnichsen N
Dermatol Monatsschr; 1980 Apr; 166(4):244-6. PubMed ID: 6893310
[No Abstract] [Full Text] [Related]
36. Extracorporeal photopheresis.
Edelson RL
Trans Am Soc Artif Intern Organs; 1984; 30():674-5. PubMed ID: 6335934
[No Abstract] [Full Text] [Related]
37. Determination of 8-methoxypsoralen kinetics: a relevant factor in the treatment of psoriasis by psoralen plus ultraviolet A therapy.
Bonnot D; Béani JC; Boitard M; Reymond JL; Bériel H; Amblard P
Photodermatol Photoimmunol Photomed; 1994 Feb; 10(1):33-7. PubMed ID: 8180098
[TBL] [Abstract][Full Text] [Related]
38. [Principles of photochemotherapy and of the determination of the initial dosage of long-wave ultraviolet rays in the photochemotherapy (PUVA) method of treatment].
Vladimirov VV
Vestn Dermatol Venerol; 1981 Jan; (1):19-24. PubMed ID: 7210865
[No Abstract] [Full Text] [Related]
39. [Modification of various cell functions of lymphocytes and granulocytes in vitro by 8-MOP without activating UVA irradiation].
Walther T; Rytter M; Gast W; Hoffmann C; Haustein UF
Dermatol Monatsschr; 1990; 176(5-6):375-8. PubMed ID: 2227056
[No Abstract] [Full Text] [Related]
40. Evaluation of time-dependent response to psoralen plus UVA (PUVA) treatment with topical 8-methoxypsoralen (8-MOP) gel in palmoplantar dermatoses.
Engin B; Oguz O
Int J Dermatol; 2005 Apr; 44(4):337-9. PubMed ID: 15811091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
